MECOM and chronic myelogenous leukemia, BCR-ABL1 positive: The majority of CML-BC LK cells showed higher Evi1 than CML-CP LSK cells, whereas CML-CP LSK cells had a wide range of Evi1, suggesting Evi1 upregulation in CML-BC model (Figure 4h).